Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Sauer

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
The New England Journal of Medicine|October 22, 2004
Preoperative versus postoperative chemoradiotherapy for rectal cancerRolf Sauer, Heinz Becker, Werner Hohenberger, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 20, 2019
Heart-sparing radiotherapy techniques in breast cancer patients: a recommendation of the breast cancer expert panel of the German society of radiation oncology (DEGRO)Marciana-Nona Duma, René Baumann, Wilfried Budach, et al.
Radiation Oncology (London, England)|January 25, 2017
Current controversies in radiotherapy for breast cancerDavid Krug, René Baumann, Wilfried Budach, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 4, 2014
DEGRO practical guidelines for radiotherapy of breast cancer IV: radiotherapy following mastectomy for invasive breast cancerFrederik Wenz, Elena Sperk, Wilfried Budach, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 13, 2018
Heart toxicity from breast cancer radiotherapy : Current findings, assessment, and preventionMarc D Piroth, René Baumann, Wilfried Budach, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2007
Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO/ARO/AIO-94Rainer Fietkau, Claus Rödel, Werner Hohenberger, et al.
Journal of the National Cancer Institute|December 6, 2017
Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal CancerEmmanouil Fokas, Philipp Ströbel, Rainer Fietkau, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 2, 2020
Post-neoadjuvant treatment with capecitabine and trastuzumab emtansine in breast cancer patients-sequentially, or better simultaneously?Marc D Piroth, David Krug, Felix Sedlmayer, et al.
Breast Care (Basel, Switzerland)|May 14, 2020
Commercially Available Gene Expression Assays as Predictive Tools for Adjuvant Radiotherapy? A Critical ReviewDavid Krug, René Baumann, Wilfried Budach, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 28, 2019
Radiotherapy after skin-sparing mastectomy with immediate breast reconstruction in intermediate-risk breast cancer : Indication and technical considerationsThomas Hehr, René Baumann, Wilfried Budach, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
The New England Journal of Medicine|October 22, 2004
Preoperative versus postoperative chemoradiotherapy for rectal cancerRolf Sauer, Heinz Becker, Werner Hohenberger, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 20, 2019
Heart-sparing radiotherapy techniques in breast cancer patients: a recommendation of the breast cancer expert panel of the German society of radiation oncology (DEGRO)Marciana-Nona Duma, René Baumann, Wilfried Budach, et al.
Radiation Oncology (London, England)|January 25, 2017
Current controversies in radiotherapy for breast cancerDavid Krug, René Baumann, Wilfried Budach, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 4, 2014
DEGRO practical guidelines for radiotherapy of breast cancer IV: radiotherapy following mastectomy for invasive breast cancerFrederik Wenz, Elena Sperk, Wilfried Budach, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 13, 2018
Heart toxicity from breast cancer radiotherapy : Current findings, assessment, and preventionMarc D Piroth, René Baumann, Wilfried Budach, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2007
Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO/ARO/AIO-94Rainer Fietkau, Claus Rödel, Werner Hohenberger, et al.
Journal of the National Cancer Institute|December 6, 2017
Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal CancerEmmanouil Fokas, Philipp Ströbel, Rainer Fietkau, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 2, 2020
Post-neoadjuvant treatment with capecitabine and trastuzumab emtansine in breast cancer patients-sequentially, or better simultaneously?Marc D Piroth, David Krug, Felix Sedlmayer, et al.
Breast Care (Basel, Switzerland)|May 14, 2020
Commercially Available Gene Expression Assays as Predictive Tools for Adjuvant Radiotherapy? A Critical ReviewDavid Krug, René Baumann, Wilfried Budach, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 28, 2019
Radiotherapy after skin-sparing mastectomy with immediate breast reconstruction in intermediate-risk breast cancer : Indication and technical considerationsThomas Hehr, René Baumann, Wilfried Budach, et al.
Pageof 15